Forschungsprojekte
Ergebnisse pro Seite:
10
2013 - 2018
PRIDE (CRFB002DDE21): Multicenter randomized open-label three-arms controlled 12 months clinical proof of concept study to evaluate efficacy and safety of Ranibizumab alone or in combination with laser photocoagulation vs. laser photocoagulation alone in Proliferative Diabetic Retinopathy- Dr. Dr. Katrin Lorenz